These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28529551)

  • 1. History and current state of immunotherapy in glioma and brain metastasis.
    McGranahan T; Li G; Nagpal S
    Ther Adv Med Oncol; 2017 May; 9(5):347-368. PubMed ID: 28529551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
    Medikonda R; Pant A; Lim M
    Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
    Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma.
    Sanders S; Debinski W
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Immunotherapeutic Approaches for Malignant Gliomas.
    Han MH; Kim CH
    Brain Tumor Res Treat; 2022 Jan; 10(1):1-11. PubMed ID: 35118842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy approaches in the treatment of malignant brain tumors.
    Dunn-Pirio AM; Vlahovic G
    Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives.
    Sener U; Ruff MW; Campian JL
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination immunotherapy strategies for glioblastoma.
    Chan HY; Choi J; Jackson C; Lim M
    J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approaches for Immune Directed Treatment for Ovarian Cancer.
    Hardwick N; Frankel PH; Cristea M
    Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective.
    Wang C; Yu M; Zhang W
    Cancer Lett; 2022 Dec; 550():215945. PubMed ID: 36216148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
    Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
    Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier.
    Frederico SC; Darling C; Bielanin JP; Dubinsky AC; Zhang X; Hadjipanayis CG; Kohanbash G
    Front Immunol; 2023; 14():1057567. PubMed ID: 36875096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario.
    Bianconi A; Palmieri G; Aruta G; Monticelli M; Zeppa P; Tartara F; Melcarne A; Garbossa D; Cofano F
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapies for glioblastoma: current state and future directions.
    Rong L; Li N; Zhang Z
    J Exp Clin Cancer Res; 2022 Apr; 41(1):142. PubMed ID: 35428347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in immunotherapy for glioblastoma multiforme.
    Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
    Front Immunol; 2022; 13():944452. PubMed ID: 36311781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
    Neagu MR; Reardon DA
    Curr Treat Options Oncol; 2015 Nov; 16(11):54. PubMed ID: 26454859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of glioblastoma immunotherapy.
    Medikonda R; Dunn G; Rahman M; Fecci P; Lim M
    J Neurooncol; 2021 Jan; 151(1):41-53. PubMed ID: 32253714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte-targeted immune checkpoint modulation in glioma.
    Kelly WJ; Giles AJ; Gilbert M
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging immunotherapies for glioblastoma.
    Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.